Codexis (CDXS) EBIT Margin (QoQ) (2010 - 2026)
Codexis (CDXS) EBIT Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Codexis | 143.86 Mn | 88.95 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,254.00 |
| Mar 31, 2026 | -7,988.00 |
| Dec 31, 2025 | 24,745.00 |
| Sep 30, 2025 | -13,640.00 |
| Jun 30, 2025 | 18,768.00 |
| Mar 31, 2025 | -23,738.00 |
| Dec 31, 2024 | 9,481.00 |
| Sep 30, 2024 | 15,588.00 |
| Jun 30, 2024 | -21,527.00 |
| Mar 31, 2024 | -7,525.00 |
| Dec 31, 2023 | 35,121.00 |
| Sep 30, 2023 | -9,307.00 |
| Jun 30, 2023 | -7,023.00 |
| Mar 31, 2023 | -11,537.00 |
| Dec 31, 2022 | -3,606.00 |
| Sep 30, 2022 | -2,406.00 |
| Jun 30, 2022 | 1,694.00 |
| Mar 31, 2022 | 1,866.00 |
| Dec 31, 2021 | -4,600.00 |
| Sep 30, 2021 | 2,124.00 |